Geschäft · 7.10.20241 Min. Lesezeit
Prospective Grant of an Exclusive Patent License: Anti-KK-LC-1 T Cell Receptors
Lokale automatische Übersetzung · Originalsprache der Quelle
Zusammenfassung
The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the Patents and Patent Applications listed in the Supplementary Information section of this notice to T-Cure Biosciences, Inc. ("T-Cure") located in Calabasas, California.